Navigation Links
Syneron Medical stellt die nächste Generation von Handstücken für die Haarentfernung mit Gentle Pro Laser und elos-Plus-Systemen vor
Date:9/3/2013

Eine Reihe wichtiger Faktoren könnte dazu führen, dass tatsächlich eintretende Ergebnisse oder Ereignisse erheblich von den in vorausschauenden Aussagen angedeuteten Ergebnissen oder Ereignissen abweichen. Dazu zählen das Risiko, dass die Geschäfte von Syneron und Canela nicht erfolgreich integriert werden können, das Risiko, dass die Fusion mit Candela unerwartete Kosten und unerwartete Verbindlichkeiten beinhalten könnte, das Risiko, dass Synergien aus der Fusionshandlung nicht in vollem Maße verwirklicht werden oder zu ihrer Verwirklichung mehr Zeit benötigen als erwartet, das Risiko, dass durch Fusionshandlungen verursachte Störungen es erschweren könnten, Beziehungen zu Kunden, Mitarbeitern oder Lieferanten aufrecht zu erhalten, sowie die Risiken, die von Syneron Medical Ltd. in dessen jüngstem Jahresbericht auf Formular 20-F dargelegt wurden, und alle weiteren Faktoren, die in den von Zeit zu Zeit bei der SEC eingereichten Berichten von Syneron Medical Ltd. erläutert werden. Sollten einer oder gleich mehrere dieser Faktoren eintreten oder sich auch nur eine der zugrundeliegenden Annahmen als unzutreffend erweisen, könnten die tatsächlichen Ergebnisse, Leistungen oder Erfolge von Syneron Medical Ltd. erheblich von den zukünftig in Aussicht gestellten Ergebnissen, Leistungen oder Erfolgen abweichen, die in diesen vorausschauenden Aussagen zum Ausdruck gebracht oder angedeutet werden.

Darüber hinaus entsprechen die in diesem Dokument enthaltenen Aussagen den Erwartungen und Überzeugungen von Syneron Medical Ltd. zum Veröffentlichungsdatum dieses Dokuments. Syneron Medical Ltd. erwartet, dass später eintretende Ereignisse und Entwicklungen zu veränderten Erwartungen und Überzeugungen führen werden. Auch wenn sich Syneron Medical Ltd. entschließen sollte, vorausschauende Aussagen in
'/>"/>

SOURCE Syneron Medical Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Arrayit Corporation Holds Successful Meeting with DHK Medical Products CEO
2. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
3. Sanomedics Announces Completion of Prime Time Medical Acquisition
4. Solta Medical Engages CT Partners to Lead CEO Search
5. South East Asia Medical Device Market Reports
6. Advances in Magnetic Resonance Imaging (MRI) Market (2013-2018) -- Technology Trend Analysis -- By Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape Analysis -- Estimates up to 2018
7. CIVETS Medical Device Market Reports
8. Central Europe and Baltic States Medical Device Market Reports
9. Northen Europe Medical Device Market Reports
10. Pharmaceutical Industry Relies on Medical Science Liaisons to Generate Value across a Diverse Set of Customers
11. X-Change Corp. Delighted with DOJs Historic Shift Toward Non-Interference Within State Cannabis Regulatory Environments; Sees Green Light for Companys Patient-Driven Medical Cannabis Operations Under State Laws
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014  Sequent Medical, ... enrollment in an Investigational Device Exemption ("IDE") pivotal ... the WEB™ Aneurysm Embolization System ("WEB"). Adam ... Department of Neurosurgery/Semmes-Murphey Clinic and Principal Investigator of ... the study, treating them with the WEB at ...
(Date:8/28/2014)... 28, 2014 GenSpera, Inc. (OTCQB: GNSZ), a ... cancer, announces the recent publication of the article "Targeting ... The recent article co-authored by Doan, et ... of GenSpera,s prodrug technology platform that is designed to ... plant Thapsia garganica ) directly to tumors. These ...
(Date:8/28/2014)... , Aug. 28, 2014 Synthetic ... novel anti-infective biologic and drug candidates targeting specific ... FUJIFILM Diosynth Biotechnologies UK Limited (Fujifilm), announced today ... of cGMP manufacturing of SYN-004, Synthetic Biologics, proprietary ... Clostridium difficile ( C. difficile ) infections. ...
Breaking Medicine Technology:Sequent Medical Announces Initiation Of IDE Study For The WEB Aneurysm Embolization System 2Sequent Medical Announces Initiation Of IDE Study For The WEB Aneurysm Embolization System 3GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 2GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 3Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 2Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 3Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 4Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 5
... TRACON Pharmaceuticals, a biotechnology company that develops targeted ... Phase 1 clinical results from studies of TRC105 and ... at the American Society of Clinical Oncology annual meeting ... programs target unique pathways with the potential for broad ...
... Ascenta Therapeutics announced today that eleven presentations or publications ... pan-Bcl-2 inhibitor, in several major tumor types will be ... (ASCO) Annual Meeting, May 29-June 2, in Orlando, Florida. ... .(Logo: http://www.newscom.com/cgi-bin/prnh/20090227/PH75873LOGO ...
Cached Medicine Technology:TRACON Pharmaceuticals' Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009 2Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting 2Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting 3
(Date:8/28/2014)... to prevent Ebola virus disease will begin next week ... (NIAID), part of the National Institutes of Health. , ... a vaccine co-developed by NIAID and GlaxoSmithKline (GSK) and ... generate an immune system response in healthy adults. Testing ... Bethesda, Maryland. , The study is the first of ...
(Date:8/28/2014)... patients in the study who were on a class ... them as prescribed in the first six months. Patients ... hospitals around the UK involved in the study. , ... and Genomics at The University of Manchester, who led ... correctly, known as ,non-adherence, reduced their effectiveness and may ...
(Date:8/28/2014)... AmeriPride Services, a leading textile services and supply ... its new Customer Portal, an online resource that makes ... for customers. The industry-leading digital tool allows customers to ... company. , Features of the new customer portal include ... and pay bills online , View delivery ...
(Date:8/28/2014)... 2014 Clarity PSO , an ... as a federal Patient Safety Organization (PSO) for another ... Healthcare Research and Quality (AHRQ). Clarity PSO will continue ... services following the true intentions of the Patient Safety ... are proud and eager to continue our journey as ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Genetic ... available throughout the world, with large reference laboratories ... Since laboratories differ with regard to the genetic ... costs, payers may struggle to find the most ... To help clients sort through these differences, Hayes, ...
Breaking Medicine News(10 mins):Health News:NIH to Launch human safety study of Ebola vaccine candidate 2Health News:NIH to Launch human safety study of Ebola vaccine candidate 3Health News:NIH to Launch human safety study of Ebola vaccine candidate 4Health News:NIH to Launch human safety study of Ebola vaccine candidate 5Health News:Arthritis patients failing to take expensive medication, according to new research 2Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Hayes, Inc. Unveils Laboratory Comparison Tables for GTE Clients 2
... Parents of children with allergies are prone to increased ... ,According to foodconsumer.org, children of parents who ... according to a new study by researchers at Cincinnati ... for allergies are twice as likely to snore. ...
... study conducted on 2500 patients has suggested that women who ... dementia. A Mayo Clinic, Minnesota team has revealed that young ... the age of 38, face a risk enhanced by 260%. ... Neurology. ,Researchers have zeroed in on the possible reason ...
... friend who was a colleague of the murdered nurse, Cheryl Moss ... killed. //When speaking to the press outside the St George's Hospital ... on the Canvey ward. She said that Cheryl was desperate to ... that one among them was murdered in the common smoking spot. ...
... is a genetic disorder that affects the heart's largest artery, ... bottom of the disease and researchers at Johns Hopkins University// ... the blood-pressure drug that has shown promise in recent studies ... Hopkins University said that the Merck's drug appears to prevent ...
... to the fumes of solvents used in house renovations.Contact ... give rise to allergies in young children, said Norbert ... ,Pregnant women should leave renovation work to ... the work area altogether. ,'It is also ...
... culling of poultry began in Niger one of the world’s ... an outbreak of deadly// avian flu near its southern border ... culling of all poultry in affected areas on February 28, ... has now appealed for international help, as it lacked the ...
Cached Medicine News:Health News:Children Of Snoring Parents Are More Likely To Inherit Themselves 2Health News:Cognitive Impairment or Dementia Risk, Pronounced with Ovary loss 2Health News:Delayed Start By Niger On Culling Of Poultry 2Health News:Delayed Start By Niger On Culling Of Poultry 3
... The Isoseeds I-125 are brachytherapy sources which ... of localized tumors, especially in the prostate. ... the conclusion of the therapeutic effect, i.e. ... are intended for single use. They are ...
... Four 64 mirrors for complete ... lens rotation. Directly hand held for ... or small holding ring. Small diameter ... gonioscopy without methylcellulose. Advanced technology, multi-layer ...
... Three mirrors of 64, ... small diameter contact surface for ... can be viewed through the ... Multi-layer polymer coating protects mirrors ...
West lacrimal cannula blunt tip with side port....
Medicine Products: